Total
0
Shares
Image Sourced ShutterStock
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Singular Health Group (SHG) has released its Medical File Transfer Protocol (MFTP), allowing practitioners to securely send and receive medical data
  • The MFTP compliments SHG’s existing Scan to Surgery program and its 3Dicom Viewer technology
  • The company’s new MFTP product acts as a transfer method, allowing medical images to be shared between practitioners and patients
  • SHG says the MFTP also uses a blockchain base, allowing for a full audit of who has accessed a patient’s private medical information
  • SHG shares are up 4.76 per cent at 33 cents each

Singular Health Group (SHG) has released its Medical File Transfer Protocol (MFTP), allowing practitioners to securely send and receive diagnostics data.

The healthcare business released its MFTP product as part of the wider 3Dicom v2.5.0 software release.

SHG said the MFTP compliments its Scan to Surgery and 3Dicom Viewer technologies.

As the company explained, MFTP acts as a transfer software that allows medical images to be shared between practitioners and patients.

“MFTP acts as a backbone infrastructure for transfer of medical images and 3D design files between different modalities to share imaging files for the 3Dicom software on desktop, mobile devices and VR headsets throughout the Scan to SurgeryTM process,” the company explained.

Chief Technology Officer Thomas Morrell said the MFTP also uses a blockchain base, allowing for a full audit of who has accessed a patient’s private medical information.

Mr Morrell said he’s proud of how SHG’s entire tech suite allows for the secure transfer of medical images.

“The ability to quickly and securely transfer the actual DICOM and design files from practitioner-to-practitioner and practitioner-to-patient provides numerous future opportunities for telehealth, collaborative review and design, and a better involvement of all stakeholders in a patient’s journey.

“I’m very proud of our dedicated developers to deliver such a complex system and
integrate it into our existing software.”

SHG shares were trading up 4.76 per cent at 33 cents each at 1:08 pm AEST.

SHG by the numbers
More From The Market Herald
Chimeric Therapeutics (ASX:CHM) - CEO and MD, Jennifer Chow

" Chimeric Therapeutics (ASX:CHM) completes first milestone on path to clinical trial

Chimeric Therapeutics (CHM) has manufactured its phase one plasmids for its clinical trial.
Rhythm Biosciences (ASX:RHY) - Chairman, Otto Buttula

" Rhythm Biosciences (ASX:RHY) nears ColoSTAT commercialisation

Cancer diagnostics technology company Rhythm Biosciences (RHY) has updated the market regarding the commercialisation of ColoSTAT.

" Epsilon (ASX:EPN) signs manufacturing agreement for Jamaican cannabis

Epsilon Healthcare (EPN) has signed a long term manufacturing agreement for Cannim’s Jamaican cannabis products.
Suda Pharmaceuticals (ASX:SUD) - CEO and MD, Michael Baker

" SUDA Pharmaceuticals (ASX:SUD) has insomnia treatment approved in Chile

SUDA Pharmaceuticals (SUD) has had its lead product, ZolpiMist, for short-term insomnia in adults, approved by the Chile Ministry of Health.